" class="no-js "lang="en-US"> Alisa Thoren, Author at Medtech Alert - Page 2 of 191
Saturday, December 09, 2023

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Olympus Launches THUNDERBEAT Energy Device for Open Surgery

Olympus Corporation (Olympus), a global medtech company committed to making people’s lives healthier, safer, and […]

Pheon Therapeutics Launches with $68 Million in Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Solid Tumors

Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide […]

First-Ever Spinal Surgical Hand-held Robot by Point Robotics MedTech to Make Its Worldwide Debut in the United States

Point Robotics MedTech Inc. (Point Robotics), a rising star in the field of orthopedic surgery, […]

Fluent Biosciences Launches Industry's First Single Tube 100,000 Cell Product to Enable Unprecedented Scale, Cost-efficiency and Access for Single-cell RNA Sequencing

Fluent BioSciences, a life sciences company focused on making single-cell analysis simple and accessible to […]

Flagship Biosciences Hires Tom Turi, Ph.D., as New Chief Scientific Officer

Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the hiring […]

Novavax Makes One Million Doses of Nuvaxovid™ Available for Use in the United Kingdom

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for […]

Cue Health Appoints Suzanne Stone as New Chief Commercial Officer

Cue Health Inc. (“Cue”) ( Nasdaq: HLTH), a healthcare technology company, today announced that it has appointed Suzanne […]

Nemaura and EVERSANA sign preliminary agreement for large-scale launch of Nemaura’s Diabetes Management Program in the U.S.

Nemaura Medical, Inc.(NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and […]

CraniUS Closes ~$20 Million Series A Funding Round

CraniUS LLC, an R&D company focused on building groundbreaking treatments for patients with chronic brain […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more